Our Science – Aprelikova Website
Olga Aprelikova, Ph.D.
![]() |
![]() |
|
Biography
Dr. Aprelikova received both her bachelor and master's degree in biochemistry from Moscow University and her Ph.D. from Institute of Cytology in St. Petersburg. She continued her postdoctoral training in the Friedrich Miescher Institute in Basel, Switzerland, in the Laboratory of Dr. Joseph Jiricny, where she focused on the repair of spontaneous DNA lesions, and then in the University of Helsinki in the Laboratory of Dr. Kari Alitalo, where she identified, cloned and characterized the novel VEGF receptor, FLT4. In 1993 she joined the Laboratory of Dr. Edison Liu in the UNC at Chapel Hill, where she studied the biological function of BRCA1. She started working at NCI in 1997 and continued research in breast cancer, and later, in tumor hypoxia.
This page was last updated on 7/15/2008.